HeartBeam rises on FDA clearance for heart-monitoring device

Heartbeam

16/12/2024 14:07

** Shares of medical device maker HeartBeam  BEAT.O  rise
9.3% to $3.55 in premarket trading
    ** Company says the U.S. FDA cleared its device that can
record the heart's electrical activity and help in detecting
irregular heartbeats
    ** Says the credit card-sized device, when placed on the
patient's chest, works by capturing the signals, which are then
processed and sent to a physician for review 
    ** Up to last close, stock up 32.8% YTD

    

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))